sb 202190 has been researched along with Left Ventricular Dysfunction in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute endotoxemia was induced by LPS (10 mg/kg, i." | 1.32 | Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. ( Feng, Q; Lei, M; Lu, X; Moe, GW; Peng, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, T | 1 |
| Lu, X | 1 |
| Lei, M | 1 |
| Moe, GW | 1 |
| Feng, Q | 1 |
1 other study available for sb 202190 and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia.
Topics: Acute Disease; Animals; Endotoxemia; Etanercept; Imidazoles; Immunoglobulin G; Immunologic Factors; | 2003 |